ICD-10 Coding for Lung Carcinoma(C34.0, C34.11, C34.11B)
Explore detailed ICD-10 coding guidelines for lung carcinoma, including primary and metastatic codes, documentation requirements, and common pitfalls.
Complete code families applicable to Lung Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung | Use when a malignant tumor is confirmed in the right upper lobe of the lung. |
|
| C78.02 | Secondary malignant neoplasm of left lung | Use for metastatic lesions in the left lung originating from another primary site. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLung Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lung Carcinoma.
Using unspecified codes (C34.90) without detailed documentation
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation
Ensure detailed documentation of tumor location., Use specific codes whenever possible.
Misidentifying primary vs. secondary neoplasm
Impact
Reimbursement: Incorrect DRG assignment may affect reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.
Mitigation
Verify primary site and document clearly in the medical record.
Laterality documentation
Impact
Failure to document laterality can lead to incorrect coding.
Mitigation
Implement mandatory laterality checks in documentation workflows.